Pharmaceuticals / Biotechnology
Strategy for the whole development journey.
From lead candidate selection through first-in-human and later-stage studies, to registration.
Our Approach
Operational advice grounded in your clinical intentions.
EdGe Toxicology draws on extensive experience to help clients plan and execute their development programmes. That support can be specific to a select stage of development, or an integrated development plan for the whole product; from lead candidate selection, through first-in-human and later-stage clinical studies, to registration.
Disciplines & therapeutic areas.
We operate across a variety of disciplines and therapeutic routes; including, and not limited to, the following.

DISCIPLINES INCLUDE:
Small molecular entities
Vaccines & biologicals
Combination products
And more
THERAPEUTIC AREAS INCLUDE:
Oncology
CNS
Cardiovascular
Anti-infectives
Ocular
Dermal
And more
Don't see your discipline or therapeutic area listed? Chances are we've worked in it. Get in touch and let's talk.
Examples of our work
What we deliver.
Our work spans the practical and regulatory demands of nonclinical development, from study oversight through to submission-ready documentation. We provide experienced, flexible support that helps programmes stay on track, resolve issues efficiently and meet regulatory expectations.

Study monitoring & coordination
Acting as your single point of contact for outsourced studies. Interpreting results, contingency planning and troubleshooting, report review, and summarisation and integration into regulatory documents.

Regulatory writing
Nonclinical documentation for regulatory submissions at clinical trial and marketing authorisation stages.

Impurity & excipient assessment
Toxicological assessments of impurities and excipients according to ICH Q3D, ICH Q3C and ICH M7.
